High Throughput Screening (HTS) Market Set to Reach $47.41 Billion by 2031, According to Meticulous Research®
Meticulous Research®, a globally recognized market research
firm, has released its latest analysis of the High Throughput Screening (HTS)
market, forecasting a remarkable growth trajectory. The market is projected to
reach $47.41 billion by 2031, growing at a CAGR of 10.1% between
2024 and 2031.
Download the Sample Report Here
Market Growth Drivers
The HTS market's expansion is driven by several key factors:
- Rising
adoption of advanced HTS technologies by pharmaceutical and
biotechnology firms
- Increased
funding for drug discovery efforts
- A
growing number of drug targets due to technological advancements
- Expanding
HTS facility installations
However, the market’s growth is tempered by significant
challenges, such as high initial capital requirements and the evolving
landscape of government regulations impacting drug development.
Key Market Trends
The report outlines important trends shaping the future of
the HTS market, including:
- The
rise of multiplexed HTS assays and the miniaturization of
technologies
- Increasing
integration of artificial intelligence (AI) in HTS processes
- The
growth of Ultra-High-Throughput Screening (uHTS) systems
- Expanding
adoption of organ-on-chip technologies
These advancements are unlocking new growth opportunities,
particularly in emerging markets such as India and Singapore, where the
biotechnology sector is rapidly expanding.
Despite these opportunities, challenges like complex data
management and the risk of false positive results in screening
assays remain as potential roadblocks.
Segment Insights
1. Consumables and Reagents:
The consumables and reagents segment is expected to hold the largest
share in 2024, driven by continuous innovations in kit development, the availability
of reagents, and frequent use of HTS consumables in research processes.
2. Cell-Based Assays Technology:
Among HTS technologies, cell-based assays, particularly 3D cell
cultures, are expected to lead the market. 3D cell cultures offer superior
replication of organ microarchitecture, enabling more accurate in
vivo studies and improved drug response predictions.
3. Applications – Target Identification:
Target identification will dominate the market in 2024, driven by the
rising costs of drug development. Pharmaceutical and biotech companies are
increasingly focusing on early-stage drug discovery, where HTS plays a
critical role.
4. End-User Segment – Pharmaceutical and Biotech
Industries:
The pharmaceutical and biotechnology industries are forecasted to remain
the largest end-users of HTS technologies. Growing investments in R&D,
along with increased funding for new drug development, are fueling this
growth. For instance, the NIH’s research funding surged from $42
billion in 2021 to $45 billion in 2022, reflecting the rising demand
for new drug therapies.
Geographic Insights
The report offers comprehensive regional analysis, with
growth projections across North America, Europe, Asia-Pacific, Latin
America, and the Middle East & Africa.
Asia-Pacific is expected to achieve the highest
growth rate, with China leading the region. Factors such as increased
R&D investments and escalating drug discovery efforts are
contributing to this growth. Notably, China saw a record number of IND
(Investigational New Drug) and NDA (New Drug Application) approvals
in early 2022, underlining its growing influence in the global pharmaceutical
landscape.
About Meticulous Research®
Since its inception in 2010, Meticulous Research® has grown
to become a global leader in premium market research. Our in-depth
analysis and custom consulting services help businesses navigate complex
markets and seize growth opportunities.
Operating across North America, Europe, Asia-Pacific,
Latin America, and the Middle East & Africa, Meticulous Research®
provides data-backed insights and tailored solutions to meet the evolving needs
of its clients.
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment